OBSERVATIONS UPON THE EXPERIMENTAL AND CLINICAL USE OF SULFAPYRIDINE. III. THE MECHANISM OF RECOVERY FROM PNEUMOCOCCAL PNEUMONIA IN PATIENTS TREATED WITH SULFAPYRIDINE
- 30 September 1939
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 13 (4), 612-617
- https://doi.org/10.7326/0003-4819-13-4-612
Abstract
Type-specific antibodies often do not appear in the blood serum of patients ill with pneumococcal pneumonia and treated with sulfapyridine until several days after the temp. has fallen to normal. Evidence is presented that type-specific antibodies play an important role in the process of recovery from pneumococcal pneumonia following treatment with sulfapyridine. The lateness of the appearance of circulating antibodies is offered as a possible explanation for the relapses which frequently occur when sulfapyridine therapy is discontinued too soon.Keywords
This publication has 2 references indexed in Scilit:
- OBSERVATIONS UPON THE EXPERIMENTAL AND CLINICAL USE OF SULFAPYRIDINE. II. THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH SULFAPYRIDINEAnnals of Internal Medicine, 1939
- OBSERVATIONS UPON THE EXPERIMENTAL USE OF SULFAPYRIDINE. I. THE RELATION OF STRAIN RESISTANCE TO THE CHEMOTHERAPEUTIC EFFECTS OF SULFAPYRIDINE IN EXPERIMENTAL PNEUMOCOCCAL INFECTIONS IN MICEAnnals of Internal Medicine, 1939